Evidence Hub

Immunoregulatory role of quercetin in lung cancer

Carvalho C, Nendel E, Mittler S, Trump S, Geiger A, Willar J, Chiriac MT, Wirtz S et al.

Cell death discovery, 2026

Abstract

Long-term nourishment with quercetin, a naturally occurring plant flavonoid abundant in citrus fruits, buckwheat, and onions, has been associated with reduced risks of chronic diseases, including cancer. In this study, we evaluated the therapeutic potential and the anti-cancer properties of quercetin in lung cancer using in vitro, in vivo, and ex vivo models. Quercetin induced tumor cell cycle arrest via the p53-p21 axis and suppressed tumor cell migration in both the A549 and H520 human lung cancer cell lines. Moreover, it reduced oxidative stress and downregulated the protein expression of oncogenic markers such as EGFR and PD-L1 on the surface of A549 cells in a dose-response manner. Quercetin significantly attenuated the proliferation and migration of the tumor cells. In an in vivo model, quercetin decreased the tumor load without affecting the body weight. In the ex vivo model, quercetin treatment resulted in the induction of interferon alpha-2 (IFN-α2), a well-known anti-tumor cytokine. These findings demonstrate that quercetin exerts potent anti-tumoral and anti- inflammatory effects in lung cancer by regulating cell cycle, oxidative stress, and immune pathways. Overview of quercetin-induced cellular modulation in lung cancer [Created in BioRender] Quercetin had a direct effect on the tumor cell cycle, where it upregulated CDKN1A and downregulated CDK1 in both murine models and human lung cancer cell lines. Quercetin regulated the p53-p21 axis, decreased EGFR, PD-L1,…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free